Bellicum Pharmaceuticals Inc

Ticker BLCM

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Houston, Texas

Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers, solid tumors, and orphan inherited blood disorders in the United States and internationally

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (140)

Bellicum Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 140 reviews.

Bellicum Pharmaceuticals Inc

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Bellicum Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.